Ireland
--:--IST
Recruiting Not applicable

Professional Life After Breast Cancer: Feasibility of a Coaching Program for an Adapted Return to Work

NCT05056350 · tracked via the Priya Life Science France tracker
Phase
Not applicable
Started
2021-09-13
Last updated
2025-02-12

Condition(s) studied

Breast Cancer

Investigational drug(s) / intervention(s)

Questionnairesback to work coaching

Questionnaires: Quality of life questionnaires, work perception questionnaires, psychological distress questionnaire

back to work coaching: Back-to-work support program including an individual interview to identify patient needs and expectations, 7 coaching workshops (every 3 weeks +/- 15 days) and a final individual assessment post workshops

Study summary

The diagnosis of breast cancer and the treatments implemented have a significant impact on the professional situation.

Maintaining employment and/or reintegration into working life are therefore major issues for cancer patients.

This trial proposes to study the feasibility of a support/coaching program for a return to work in patients after breast cancer.

Eligibility

Sex
FEMALE
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Age ≥18 years * Patients cared at the Montpellier Cancer Institute (ICM) for non-metastatic breast cancer who have received adjuvant treatment (radiotherapy and/or chemotherapy) * Patient who has completed adjuvant treatment, except for hormonotherapy * Patient practicing a profession at the time of diagnosis, looking for a job or in professional retraining at the time of diagnosis * Patient expressing spontaneously or on request of the oncologist physical or psychological difficulties in the professional field * Patient wishing to be accompanied for an adapted return to her current job or for a return to a new more adapted job * Patient who signed the informed consent after informed information by her clinician Exclusion Criteria: * Metastatic breast cancer or any other cancer within the last 5 years * Patient who haven't completed herr adjuvant treatment (chemotherapy and/or radiotherapy) * Psychological condition requiring therapeutic support (objectified by the Mini International Neuropsychiatric Interview test (MINI) by identifying a Diagnostic and Statistical Manual (DSM)-IV Axis I psychiatric disorder (American Psychiatric Association, 1994) Sheehan et al., 1998) with the patient's refusal of adequate psychiatric treatment (medicated or not) at the time of inclusion in the study * Severely impaired global cognitive functioning (objectified by an adjusted score of less than 20 on the Montreal Cognitive Assessment (MoCA) test) * Physical inability to answer questionnaires

Primary outcome measure(s)

  • Patient adherence of a coaching program for an adapted return to work — through study completion, an average of 1 year
    Assessment of the feasibility of a support program for an adapted return to work in patients with breast cancer, after their adjuvant treatment. Feasibility is defined by the proportion of patients who have adhered to the support program, with the patient attending at least 5 of the 7 proposed sessions.

Trial sites (1)

FacilityCityRegionStatus
Institut du Cancer de Montpellier Montpellier France Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT05056350 on ClinicalTrials.gov ↗ ← All trials in France